# Beaumont Health Large-scale Automated Serologic Testing for COVID-19

> **NCT04349202** · — · COMPLETED · sponsor: **Corewell Health East** · enrollment: 20614 (actual)

## Conditions studied

- COVID-19
- Coronavirus Infection
- Severe Acute Respiratory Syndrome Coronavirus 2

## Interventions

- **DIAGNOSTIC_TEST:** EUROIMMUN assay

## Key facts

- **NCT ID:** NCT04349202
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-10
- **Primary completion:** 2021-01-19
- **Final completion:** 2021-01-19
- **Target enrollment:** 20614 (ACTUAL)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349202, "Beaumont Health Large-scale Automated Serologic Testing for COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04349202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*